glp-1 obesity drug news today sep 30 2025 Agonists Weight Loss Drugs Market Report, 2025-2030 Chart: 1 in 8 Americans

A licensed provider reviews it, and if semaglutide is a fit, writes your prescription

For humans, the model-predicted median clearance (CL) and volume of distribution (Vss) of semaglutide were 0.0397 L/h and 6.23 L, respectively

Explore the best alternatives to tirzepatide for weight loss, from semaglutide to retatrutide, compounded options, and natural approaches with data.

A glucagon-like peptide-1 (GLP-1) drug appears to slow cognitive decline by protecting the brain, according to Phase 2b clinical trial results reported at AAIC.

Then feel stronger, more in control, and more consistent over 34 months of daily use.* SUPPORT APPETITE, ENERGY, AND MOTIVATION NATURALLY: Feel fuller longer without feeling forced

Allulose is not a GLP-1 agonist, but emerging research suggests it may modulate glucose metabolism and GLP-1 secretion in ways that merit clinical attention